Molecular diagnostics uses techniques
such as nucleic acid amplification and hybridization for identification
of microorganisms and presence of virulence factors. Various molecular
assays have been developed using various technologies. These
technologies increased the accuracy of the tests, producing rapid
results.
The molecular diagnostic market for group
A streptococcus (GAS) nucleic acid (NA) tests in Europe is anticipated
to grow at a significant rate during the forecast period due to
increasing incidence of Streptococcus pyogenes infection in Europe,
advancements in technology, and rising demand for point-of-care testing.
The average annual incidence of GAS invasive disease has been estimated
to be 2.45 per 100,000 population in developed countries. The incidence
of the disease has increased at a steady rate in most countries.
Advancements in nucleic acid testing technologies and their adoption in
Europe would result in high growth of the market. Recent developments in
the field of nucleic acid testing have led to a shift of technology
from laboratory to point-of-care testing. Some of the factors
restraining the market are ineffectiveness and slow adoption rate, lack
of facilities, and regulatory challenges. Future technology enhancements
is the major opportunity in the nucleic acid tests market.
Polymerase chain reaction is an
established amplification technique for nucleic acid (NA) tests for
group A streptococcus (GAS). Recently the techniques like Non-Amplified
Tests such as Nucleic acid probes is getting popular due to its high
specificity, and there is no risk of contamination in the sample.
Isothermal nucleic acid amplification technique is being rapidly adopted
due to its high adoptability over other test methods. Loop mediated
amplification technique is a type of isothermal nucleic acid
amplification technique that is used in identification of group A
streptococcus by nucleic acid tests.
The molecular diagnostic market for group
A streptococcus (GAS) nucleic acid (NA) tests in Europe has been
estimated based on type of tests, end-user, and geography. Based on type
of test, the market has been segmented into polymerase chain reaction,
non-amplified tests, and isothermal nucleic acid amplification
technology. The polymerase chain reaction segment held the largest share
of the market in 2014. The segment is likely to continue to dominate
the market during the forecast period. The isothermal nucleic acid
amplification technology segment is estimated to record fastest growth
during the forecast period due to rising need for accurate and rapid
results.
Based on end-user, Molecular Diagnostic
Market for Group A Streptococcus (GAS) Nucleic Acid (NA) Test Product
market has been segmented into hospitals, public health laboratories,
and others. The hospitals segment held the largest share of the market
in 2014. The segment is likely to continue to dominate the market during
the forecast period.
Geographically, the molecular diagnostic
market for group A streptococcus (GAS) nucleic acid (NA) tests has been
categorized into five regions: Western Europe, Northern Europe, Southern
Europe, Eastern Europe, and Rest of Europe. Western Europe held the
largest share of the GAS nucleic acid tests market in 2014, followed by
Northern Europe. The market in the Northern region is expected to expand
at a high CAGR during the forecast period. Low market revenue and
growth in Eastern Europe and Rest of Europe is due to low adoption of
nucleic acid tests.
Alere, Inc., Meridian Bioscience, Inc.,
Nanosphere, Inc., Hologic, Inc., and F. Hoffmann-La Roche Ltd. are the
major players operating in the molecular diagnostic market for group A
streptococcus (GAS) nucleic acid (NA) tests in Europe. F. Hoffmann-La
Roche Ltd. is the leading player in the market.
No comments:
Post a Comment